Kahán, Z <br/><br/>
Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.  [electronic resource] 

 -  Cancer  Jun 1999 
 - 2608-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--chemistry<br/>Doxorubicin--analogs & derivatives<br/>Female<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Humans<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>RNA, Messenger--biosynthesis<br/>Receptors, LHRH--drug effects<br/>Transplantation, Heterologous